Cryo-Cell International Inc

Compare

54 Followers

CCEL Stock Chart & Stats

$4.40

-$0.37(-4.74%)

At close: Jan 08 4:00 PM EST

$4.40

-$0.37(-4.74%)

Day’s Range― - ―

52-Week Range$4.09 - $9.43

Previous CloseN/A

Volume3.40K

Average Volume (3M)19.02K

Market Cap

$35.04M

Enterprise Value$47.32M

Total Cash (Recent Filing)$3.22M

Total Debt (Recent Filing)$4.21M

Price to Earnings (P/E)―

Beta-0.02

Next Earnings

Feb 26, 2026

EPS Estimate

-0.03

Last Dividend Ex-Date

May 21, 2025

Dividend Yield8.86%

Share Statistics

EPS (TTM)0.09

Shares Outstanding8,055,150

10 Day Avg. Volume7,315

30 Day Avg. Volume19,023

Financial Highlights & Ratios

PEG Ratio-1.68

Price to Book (P/B)-5.33

Price to Sales (P/S)2.20

P/FCF Ratio19.54

Enterprise Value/Market Cap1.35

Enterprise Value/Revenue1.49

Enterprise Value/Gross Profit1.93

Enterprise Value/Ebitda9.20

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusHold

Number of Analyst Covering1

Bulls Say, Bears Say

Bulls Say

Core Business StrengthCryo-Cell's core business of processing and storing stem cells remains strong, with high gross margins and mostly recurring revenue.

Recurring RevenueThere is a positive outlook on the company's high margin recurring revenue.

Bears Say

Arbitration UncertaintyUncertainty surrounds the arbitration against Duke University, with potential damages exceeding $100M and a countersuit filed against the company.

Dividend SuspensionThe company suspended its dividend in August, contributing to the downgrade of the stock to Hold.

Revenue DeclineThe stock is downgraded to Hold from Buy due to declining revenue, decreased new business, and expected increased litigation costs.

Cryo-Cell International News

Cryo-Cell downgraded to Hold from Buy at Maxim

Maxim analyst Allen Klee downgraded Cryo-Cell (CCEL) to Hold from Buy. Published first on TheFly – the ultimate...

10d ago

CCEL

Cryo-Cell International Amends Credit Agreement with Susser Bank

Cryo-Cell International ( ($CCEL) ) has shared an update. Cryo-Cell International, Inc. announced a Fifth Amendment to its...

7d ago

CCEL

Cryo-Cell Schedules 2025 Annual Stockholders Meeting

Cryo-Cell International ( ($CCEL) ) has provided an announcement. Cryo-Cell International has scheduled its 2025 Annual Meeting of...

2M ago

CCEL

Cryo-Cell will not declare dividend in Q3

Cryo-Cell (CCEL) announced that the company will not declare a quarterly cash dividend for the third quarter of...

3M ago

CCEL

Cryo-Cell reports Q2 EPS 4c vs. 8c last year.

Reports Q2 revenue $7.9M vs. $8.0M last year. Published first on TheFly – the ultimate source for real-time,...

4M ago

CCEL

Cryo-Cell Faces License Termination by Duke University

Cryo-Cell International ( ($CCEL) ) has issued an update. Cryo-Cell International, Inc. has received a notice of termination...

5M ago

CCEL

Cryo-Cell International Declares Reduced Quarterly Dividend

An announcement from Cryo-Cell International ( ($CCEL) ) is now available. On May 7, 2025, Cryo-Cell International‘s Board...

6M ago

CCEL

Cryo-Cell International: Strong Financial Performance and Strategic Positioning with Potential Upside

In a report released yesterday, Allen Klee from Maxim Group reiterated a Buy rating on Cryo-Cell International (CCEL...

7M ago

CCEL

Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz

The major averages were fractionally higher near noon, adding slightly to yesterday’s gains as investors reacted to fresh...

7M ago

Cryo-Cell reports Q1 EPS 3c vs. 7c last year

Reports Q1 revenue $7.97M vs. $7.85M last year. The company said, “The revenues for the first quarter of...

7M ago

CCEL

Cryo-Cell price target lowered to $8.50 from $9 at Maxim

Maxim lowered the firm’s price target on Cryo-Cell (CCEL) to $8.50 from $9 and keeps a Buy rating...

8M ago

CCEL

Cryo-Cell reports FY24 EPS 5c vs ($1.14) last year

Reports FY24 revenue $32M vs $31.3M last year. David Portnoy, Cryo-Cell’s (CCEL) Chairman of the Board and Co-CEO...

8M ago

CCEL

CRYO-CELL International, Inc. trading resumes

09:40 EDT CRYO-CELL (CCEL) International, Inc. trading resumes Published first on TheFly – the ultimate source for real-time,...

1y ago

CCEL

CRYO-CELL International, Inc. trading halted, volatility trading pause

09:30 EDT CRYO-CELL (CCEL) International, Inc. trading halted, volatility trading pause Published first on TheFly – the ultimate...

1y ago

CCEL

CCEL FAQ

What was Cryo-Cell International Inc’s price range in the past 12 months?

Cryo-Cell International Inc lowest stock price was $4.09 and its highest was $9.43 in the past 12 months.

What is Cryo-Cell International Inc’s market cap?

Cryo-Cell International Inc’s market cap is $35.04M.

When is Cryo-Cell International Inc’s upcoming earnings report date?

Cryo-Cell International Inc’s upcoming earnings report date is Feb 26, 2026 which is in 119 days.

How were Cryo-Cell International Inc’s earnings last quarter?

Cryo-Cell International Inc released its earnings results on Oct 15, 2025. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of -$0.03 by $0.12.

Is Cryo-Cell International Inc overvalued?

According to Wall Street analysts Cryo-Cell International Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cryo-Cell International Inc pay dividends?

Cryo-Cell International Inc pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 8.86%. See more information on Cryo-Cell International Inc dividends here

What is Cryo-Cell International Inc’s EPS estimate?

Cryo-Cell International Inc’s EPS estimate is -0.03.

How many shares outstanding does Cryo-Cell International Inc have?

Cryo-Cell International Inc has 8,055,150 shares outstanding.

What happened to Cryo-Cell International Inc’s price movement after its last earnings report?

Cryo-Cell International Inc reported an EPS of $0.09 in its last earnings report, beating expectations of -$0.03. Following the earnings report the stock price went down -1.099%.

Which hedge fund is a major shareholder of Cryo-Cell International Inc?

Currently, no hedge funds are holding shares in CCEL

Cryo-Cell International Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

0.37%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Cryo-Cell International Inc

Cryo-Cell International (CCEL) is a leading biotechnology company specializing in the collection, processing, and storage of umbilical cord blood and tissue stem cells. Founded in 1992, the company operates within the regenerative medicine sector, offering services that allow families to preserve stem cells for potential future medical use. CCEL's core products include private cord blood banking services, which provide parents with the opportunity to store their newborn's stem cells for personal use, as well as public cord blood donations that contribute to research and treatment opportunities in various medical fields.

Cryo-Cell International (CCEL) Earnings & Revenues

Historic Earnings Reports

CCEL Stock 12 Month Forecast

Average Price Target

―

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","-1":"-$1","1.25":"$1.25","3.5":"$3.5","5.75":"$5.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">―</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,1.25,3.5,5.75,8],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.72,4.356923076923077,3.9938461538461536,3.6307692307692303,3.2676923076923075,2.9046153846153846,2.5415384615384613,2.178461538461538,1.8153846153846152,1.4523076923076923,1.089230769230769,0.7261538461538457,0.36307692307692285,{"y":null,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.72,4.356923076923077,3.9938461538461536,3.6307692307692303,3.2676923076923075,2.9046153846153846,2.5415384615384613,2.178461538461538,1.8153846153846152,1.4523076923076923,1.089230769230769,0.7261538461538457,0.36307692307692285,{"y":null,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.72,4.356923076923077,3.9938461538461536,3.6307692307692303,3.2676923076923075,2.9046153846153846,2.5415384615384613,2.178461538461538,1.8153846153846152,1.4523076923076923,1.089230769230769,0.7261538461538457,0.36307692307692285,{"y":null,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.49,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.82,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.79,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.71,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.59,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.97,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.67,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.26,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.05,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.97,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.07,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.96,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.72,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >